PharmaShots | Incisive News in 3 Shots

Subscribe Now

HighLife

HighLife’s TSMVR System Obtains the US FDA’s IDE Approval to Commence Clinical Trial for Treating Mitral Regurgitation

HighLife’s TSMVR System Obtains the US FDA’s IDE Approval to Commence Clinical Trial for Treating Mitral Regurgitation

June 4, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us